Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to $64768.0.

  • Ensysce Biosciences' Non-cash Items fell 8884.11% to $64768.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $64768.0, marking a year-over-year decrease of 8884.11%. This contributed to the annual value of $38734.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Ensysce Biosciences reported Non-cash Items of $64768.0 as of Q3 2025, which was down 8884.11% from $51758.0 recorded in Q2 2025.
  • Ensysce Biosciences' 5-year Non-cash Items high stood at $53.7 million for Q2 2021, and its period low was $23922.0 during Q1 2023.
  • Moreover, its 5-year median value for Non-cash Items was $279306.0 (2022), whereas its average is $5.0 million.
  • In the last 5 years, Ensysce Biosciences' Non-cash Items crashed by 9991.34% in 2022 and then surged by 226855.34% in 2024.
  • Quarter analysis of 5 years shows Ensysce Biosciences' Non-cash Items stood at $10.2 million in 2021, then tumbled by 97.26% to $279306.0 in 2022, then crashed by 91.23% to $24505.0 in 2023, then soared by 58.07% to $38734.0 in 2024, then skyrocketed by 67.21% to $64768.0 in 2025.
  • Its Non-cash Items was $64768.0 in Q3 2025, compared to $51758.0 in Q2 2025 and $38749.0 in Q1 2025.